JP2018526459A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018526459A5 JP2018526459A5 JP2018532806A JP2018532806A JP2018526459A5 JP 2018526459 A5 JP2018526459 A5 JP 2018526459A5 JP 2018532806 A JP2018532806 A JP 2018532806A JP 2018532806 A JP2018532806 A JP 2018532806A JP 2018526459 A5 JP2018526459 A5 JP 2018526459A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- treatment
- administered
- day
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 102000000588 Interleukin-2 Human genes 0.000 claims description 9
- 108010002350 Interleukin-2 Proteins 0.000 claims description 9
- 238000011282 treatment Methods 0.000 claims description 9
- 208000006045 Spondylarthropathies Diseases 0.000 claims description 5
- 201000005671 spondyloarthropathy Diseases 0.000 claims description 5
- 239000008194 pharmaceutical composition Substances 0.000 claims 15
- 239000000203 mixture Substances 0.000 claims 7
- 238000009115 maintenance therapy Methods 0.000 claims 3
- 208000024891 symptom Diseases 0.000 claims 3
- 206010002556 Ankylosing Spondylitis Diseases 0.000 claims 1
- 208000036487 Arthropathies Diseases 0.000 claims 1
- 208000012659 Joint disease Diseases 0.000 claims 1
- 206010023230 Joint stiffness Diseases 0.000 claims 1
- 208000002193 Pain Diseases 0.000 claims 1
- 206010046851 Uveitis Diseases 0.000 claims 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 230000002757 inflammatory effect Effects 0.000 claims 1
- 208000018934 joint symptom Diseases 0.000 claims 1
- 238000011321 prophylaxis Methods 0.000 claims 1
- 238000012423 maintenance Methods 0.000 description 3
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15306383 | 2015-09-10 | ||
| EP15306383.9 | 2015-09-10 | ||
| PCT/EP2016/071370 WO2017042370A1 (en) | 2015-09-10 | 2016-09-09 | Use of interleukin 2 for treating spondyloarthritis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018526459A JP2018526459A (ja) | 2018-09-13 |
| JP2018526459A5 true JP2018526459A5 (enExample) | 2019-10-17 |
Family
ID=54145708
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018532806A Pending JP2018526459A (ja) | 2015-09-10 | 2016-09-09 | 脊椎関節症の処置のためのインターロイキン−２の使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20190060407A1 (enExample) |
| EP (1) | EP3347036A1 (enExample) |
| JP (1) | JP2018526459A (enExample) |
| AU (1) | AU2016319292A1 (enExample) |
| CA (1) | CA2997946A1 (enExample) |
| WO (1) | WO2017042370A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3713592A4 (en) | 2017-11-21 | 2022-01-12 | The Board of Trustees of the Leland Stanford Junior University | INTERLEUKIN-2 PARTIAL AGONISTS |
| WO2019158764A1 (en) * | 2018-02-16 | 2019-08-22 | Iltoo Pharma | Use of interleukin 2 for treating sjögren's syndrome |
| WO2020007937A1 (en) * | 2018-07-03 | 2020-01-09 | Iltoo Pharma | Use of interleukin-2 for treating systemic sclerosis |
| MX2021001264A (es) | 2018-08-01 | 2021-07-02 | Taris Biomedical Llc | Métodos para tratar la vejiga hiperactiva con el uso de trospio. |
| CN115362168A (zh) | 2020-01-14 | 2022-11-18 | 辛德凯因股份有限公司 | 偏向化il2突变蛋白方法和组合物 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX347324B (es) * | 2011-03-11 | 2017-04-19 | Assist Publique-Hôpitaux De Paris | Uso de dosis bajas de il-2 para tratar trastornos inflamatorios o relacionados con la autoinmunidad. |
| CN104189892A (zh) * | 2014-08-22 | 2014-12-10 | 北京大学人民医院 | 低剂量白细胞介素2在免疫相关性疾病治疗中的应用 |
-
2016
- 2016-09-09 AU AU2016319292A patent/AU2016319292A1/en not_active Abandoned
- 2016-09-09 US US15/758,800 patent/US20190060407A1/en not_active Abandoned
- 2016-09-09 WO PCT/EP2016/071370 patent/WO2017042370A1/en not_active Ceased
- 2016-09-09 CA CA2997946A patent/CA2997946A1/en not_active Abandoned
- 2016-09-09 EP EP16770224.0A patent/EP3347036A1/en not_active Withdrawn
- 2016-09-09 JP JP2018532806A patent/JP2018526459A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018526459A5 (enExample) | ||
| MX2024008539A (es) | Compuestos bifuncionales para degradar la tirosina cinasa de bruton (btk) mediante la trayectoria de ubiquitina proteosoma. | |
| JP2012193216A5 (enExample) | ||
| JP2018193377A5 (enExample) | ||
| Edwards et al. | Emerging therapies for gout | |
| JP2013505205A5 (enExample) | ||
| JP2015517488A5 (enExample) | ||
| JP2018530578A5 (enExample) | ||
| EA201892657A1 (ru) | Спиролактамовые модуляторы nmda-рецептора и их применение | |
| UY35624A (es) | Uso de dosis elevadas de pridopidina para tratar la enfermedad de huntington | |
| PH12016502391B1 (en) | Composition for treating diabetes, comprising long-acting insulin analogue conjugate and long-acting insulinotropic peptide conjugate | |
| JP2018507243A5 (enExample) | ||
| JP2017160178A5 (enExample) | ||
| RU2017134443A (ru) | Способ лечения с применением традипитанта | |
| EA201990428A1 (ru) | Спиролактамовые модуляторы nmda-рецептора и их применение | |
| JP2016510343A5 (enExample) | ||
| JP2020533302A5 (enExample) | ||
| JP2011190199A5 (enExample) | ||
| JP2017533220A5 (enExample) | ||
| JP2017014206A5 (enExample) | ||
| JP2017512194A5 (enExample) | ||
| JP2014520856A5 (enExample) | ||
| JP2014507475A5 (enExample) | ||
| RU2016109085A (ru) | Применение иммунорегуляторного белка ганодерма (rlz-8) в получении лекарственного средства для лечения меланомы | |
| RU2013157398A (ru) | Композиция |